These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 30246632)

  • 61. Histological assessment of follicular delivery of flutamide by solid lipid nanoparticles: potential tool for the treatment of androgenic alopecia.
    Hamishehkar H; Ghanbarzadeh S; Sepehran S; Javadzadeh Y; Adib ZM; Kouhsoltani M
    Drug Dev Ind Pharm; 2016; 42(6):846-53. PubMed ID: 26154267
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Design and evaluation of lidocaine- and prilocaine-coloaded nanoparticulate drug delivery systems for topical anesthetic analgesic therapy: a comparison between solid lipid nanoparticles and nanostructured lipid carriers.
    You P; Yuan R; Chen C
    Drug Des Devel Ther; 2017; 11():2743-2752. PubMed ID: 29075099
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Solid Lipid Nanoparticles for Topical Drug Delivery: Mechanisms, Dosage Form Perspectives, and Translational Status.
    Liu M; Wen J; Sharma M
    Curr Pharm Des; 2020; 26(27):3203-3217. PubMed ID: 32452322
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Skin permeation: the years of enlightenment.
    Hadgraft J; Lane ME
    Int J Pharm; 2005 Nov; 305(1-2):2-12. PubMed ID: 16246513
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Microemulsions: applications in transdermal and dermal delivery.
    Date AA; Patravale VB
    Crit Rev Ther Drug Carrier Syst; 2007; 24(6):547-96. PubMed ID: 18298390
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of surface chemistry of polymeric nanoparticles on cutaneous penetration of cholecalciferol.
    Lalloz A; Bolzinger MA; Faivre J; Latreille PL; Garcia Ac A; Rakotovao C; Rabanel JM; Hildgen P; Banquy X; Briançon S
    Int J Pharm; 2018 Dec; 553(1-2):120-131. PubMed ID: 30316003
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Liposome surface charge influence on skin penetration behaviour.
    Gillet A; Compère P; Lecomte F; Hubert P; Ducat E; Evrard B; Piel G
    Int J Pharm; 2011 Jun; 411(1-2):223-31. PubMed ID: 21458550
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gold nanoparticles for skin drug delivery.
    Chen Y; Feng X
    Int J Pharm; 2022 Sep; 625():122122. PubMed ID: 35987319
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Recent advances in transdermal drug delivery.
    Subedi RK; Oh SY; Chun MK; Choi HK
    Arch Pharm Res; 2010 Mar; 33(3):339-51. PubMed ID: 20361297
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ask the experts: transdermal drug delivery.
    Ther Deliv; 2013 Oct; 4(10):1235-8. PubMed ID: 24116908
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
    Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
    Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: Formulation development, stability issues, basic considerations and applications.
    Rai VK; Mishra N; Yadav KS; Yadav NP
    J Control Release; 2018 Jan; 270():203-225. PubMed ID: 29199062
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Progress in the use of microemulsions for transdermal and dermal drug delivery.
    Ita K
    Pharm Dev Technol; 2017 Jun; 22(4):467-475. PubMed ID: 26931453
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combined multiphoton imaging-pixel analysis for semiquantitation of skin penetration of gold nanoparticles.
    Labouta HI; Kraus T; El-Khordagui LK; Schneider M
    Int J Pharm; 2011 Jul; 413(1-2):279-82. PubMed ID: 21515347
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A Nanocarrier Skin-Targeted Drug Delivery System using an Ascorbic Acid Derivative.
    Inoue Y; Hibino M; Murata I; Kanamoto I
    Pharm Res; 2017 Dec; 35(1):1. PubMed ID: 29285607
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration.
    Singh G; Pai RS
    J Pharm Pharmacol; 2014 Aug; 66(8):1062-76. PubMed ID: 24779896
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Recent Progress in Transdermal Nanocarriers and Their Surface Modifications.
    Yu Z; Meng X; Zhang S; Chen Y; Zhang Z; Zhang Y
    Molecules; 2021 May; 26(11):. PubMed ID: 34064297
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy.
    Wang Y; Wang S; Shi P
    Drug Deliv; 2016 Nov; 23(9):3193-3199. PubMed ID: 27045388
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Influence of sonophoresis on transdermal drug delivery of hydrophilic compound-loaded lipid nanocarriers.
    Rangsimawong W; Opanasopit P; Rojanarata T; Panomsuk S; Ngawhirunpat T
    Pharm Dev Technol; 2017 Jun; 22(4):597-605. PubMed ID: 27492948
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.